
IRA
SHAFRAN
M.D.,
P.A.
As a Board Certified Gastroenterologist practicing in the Orlando area since 1979, Dr. Shafran completed his Internal Medicine & GI training at Ohio State University Medical School. During the past several years, he has been on the forefront of researching a cause & a cure for Crohn's disease. He continues to pursue ground breaking research, producing numerous publications and becoming internationally renown for his expertise using novel, successful therapies for Inflammatory Bowel Disease. Dr. Shafran was acknowledged as one of America's "Top" Gastroenterologist in the Guide to Top Doctors '99 publication. He is considered among the "Top 70 Doctors" in Central Florida according to his peers and featured in the Orlando Magazine's December 2000 and 2001 issues. Frequently, he can be seen on TV for newsworthy GI developments on America's Health Network and PBS HealthWeek. Featured in Saturday Evening Post's May-June 2004 article, Reducing the Risk of Crohn's Disease. He has also been an outspoken patient advocate & supporter of Patient Rights. At the Shafran Gastroenterology Center, our associates & staff take great pride in providing our patients with the highest quality medical care in a warm & friendly way, tailoring treatment to meet each patient’s specific needs.
|
|
|
|
|
| 1967-1971 | B Sc., in Zoology, cum laude; Ohio State University, Columbus, OH |
| 1971-1974 | M.D., cum laude; Ohio State University, Columbus, OH |
| 1974-1975 | Medical Internship; Ohio State University Hospital, Columbus, OH |
| 1975-1977 | Medical Residency; Ohio State University Hospital, Columbus, OH |
| 1977-1979 | Gastroenterology Fellowship; Ohio State Univ. Hospital, Columbus, OH |
| BOARD CERTIFICATION | |
| 6/1977 | American Board of Internal Medicine #61873 |
| 6/1979 | American Board of Internal Medicine, Subspecialty of Gastroenterology #61873 |
| PROFESSIONAL EXPERIENCE | |
| 1975-1979 | Participated in National Cooperative on Crohn's Disease |
| 1979-Present | Private Practice in Gastroenterology in Orlando, FL
Assistant Professor-Internal Medicine/Gastroenterology-University South Florida Assistant Professor-Internal Medicine/Gastroenterology-Florida Hospital, Orlando, FL Dr. Shafran performs procedures at Florida Hospital South (601 E. Rollins St., Orlando) and at the MNH Surgery Center ( 1101 North Maitland Avenue, Suite #4, Maitland). |
| 1978-Present | Active Medical Staff, Florida Hospital |
| 1979-1996 | Active Medical Staff, Winter Park Memorial Hospital |
| 1980-1990 | Chairman Department of Endoscopy, Florida Hospital, Orlando, FL |
| 1984-1996 | Active Medical Staff, South Seminole Community Hospital |
| 1992-1997 | Chairman Department of Endoscopy, Florida Hospital, Orlando, FL |
| 1990-Present | Risk Management Advisor, Florida Hospital, Orlando, FL |
| 1990-Present | Founder, Concerned Physicians of America, Non-profit organization asserting the rights of the Doctors and the Patients |
| 1994-Present | Volunteer Physician, Health Care Clinic for the Homeless, Orlando, FL |
| 1997 | Special Advisor to Florida Hospital. Dr. Shafran performs procedures at Florida Hospital South (601 E. Rollins St., Orlando) and at the MNH Surgery Center ( 1101 North Maitland Avenue, Suite #4, Maitland). |
| PUBLICATIONS (separate page) | |
| ORGANIZATIONS & SOCIETY MEMBERSHIPS | |
|
Current
Past |
|
| EDUCATOR | |
|
|
| QUALITY ASSURANCE | |
|
|
| MEDICAL-LEGAL | |
|
|
| PATIENTS' RIGHTS ADVOCATE & HEALTH CARE REFORM | |
|
|
| CURRENT RESEARCH INTERESTS | |
|
PUBLICATIONS |
|
|
In
Situ identification of mycobacteria in
Crohn’s disease patient tissue using confocal scanning laser microscopy. Open
clinical trial of Rifabutin and Clarithromycin therapy in Crohn’s Disease.
Mycobacterium
avium subsp. Paratuberculosis as one cause of Crohn's Disease Use of Short Term
Culture for Identification of Mycobacterium avium subsp. Paratuberculosis in
Tissue from Crohn’s Disease Patients. Isolation of
Mycobacterium avium subsp. Paratuberculosis from Breast Milk of Crohn’s
Disease Patients. Fistula Healing in MAP
Positive Crohn’s Disease Patients Following Rifabutin and Macrolide Antibiotic
Treatment. A Comparative Analysis of
Anti-Saccharomyces Antibodies (ASCA) and p35 and p36 Recombinant Clones for the
Diagnosis of Crohn's Disease (CD) Cost Analysis of Antibiotic
Treatment in Crohn’s Disease Patients Serologically Positive for
Mycobacterium avium ss. paratuberculosis. Mycobacterium Identification in
Stool Cultures of IBD Patients Serologically Positive for Mycobacterium avium
ss. paratuberculosis. Identification
of Mycobacterium avium ss. paratuberculosis in Crohn's Tissue. Rifabutin
and Macrolide Antibiotic Treatment in Crohn’s Patients Identified
Serologically Positive for Mycobacterium avium ss. paratuberculosis. Specific seroreactivity of Crohn's
disease patients against p35 and p36 antigens of M. avium subsp.
paratuberculosis. Comparison of Serolgic
Markers for the Diagnosis of Crohn’s Disease. Serum sickness-like
illness in Crohn’s Disease Patients Treated With Antibiotics. Treatment of
Crohn’s Disease with Rifabutin and Macrolide Antibiotics. Mycobacterium
Avium, SS Paratuberculosis, in Crohn’s Disease is an Affirmative. In
Vitro Evaluation of Anti-Tuberculous Drugs Against M. Avium, Subspecies
Paratuberculosis, for Treatment of Crohn’s’ Disease. Endoscopic
Healing of Crohn’s Disease After Antibiotic Treatment. Humeral
Immune Response of Crohn’s Patients for Mycobacterium Avium, Subspecies
Paratuberculosis. In
Vitro Evaluation of Anti-Tuberculous Drugs Against Mycobacterium Avium
Subspecies Paratuberculosis for Treatment of Crohn’s Disease. Rapid
Culturing and PCR Detection of Mycobacterium Avium, SS. Paratuberculosis,
from Crohn’s Disease Tissue. Mycobacterium avium subsp.
Paratuberculosis in Crohn’s Disease Is Serologically Positive Specific Seroreactivity of Crohn’s Disease Patients Against P 35 and P 36 Antigens of M. Avium Subspecies Paratuberculosis, S.A. Naser, K. Hulten, I. Shafran, D.Y. Graham, F. El-Zaatari, presented at the 1999 6th International Colloquium on Paratuberculosis in Melbourne, Australia. The Use of
Combined Antigens for Specific Diagnosis of Crohn’ Disease. |